Comparison of Resting State EEG Power Spectra Between Adults with High Body Mass Index and Normal Body Mass Index- Principal Investigator
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - 2024
Project Lead
Dr. Jinu Sherbin
Authors
Dr. Jinu Sherbin, Dr. Saranya Kuppusamy, Dr. Pravati Pal, Dr. G. P. Senthil Kumar, Dr. K.T. Harichandrakumar, Dr. Senthil Kumar Subramanian
Project Status
completed